CN Patent

CN108349898B — 富马酸贝达喹啉的晶型及其制备方法

Assigned to Zhejiang Hisun Pharmaceutical Co Ltd · Expires 2021-03-23 · 5y expired

What this patent protects

提供了一种富马酸贝达喹啉的晶型I、II和III及其制备方法，该晶型纯度高，理化性质优异，稳定性好。所述制备方法能有效提高产品质量，适用于药物的制备和大规模生产。

USPTO Abstract

提供了一种富马酸贝达喹啉的晶型I、II和III及其制备方法，该晶型纯度高，理化性质优异，稳定性好。所述制备方法能有效提高产品质量，适用于药物的制备和大规模生产。

Drugs covered by this patent

bedaquiline-fumarate (BEDAQUILINE FUMARATE)

Patent Metadata

Patent number: CN108349898B
Jurisdiction: CN
Classification: —
Expires: 2021-03-23
Drug substance claim: No
Drug product claim: No
Assignee: Zhejiang Hisun Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.